Acessibilidade / Reportar erro

New Terpenoids from Croton limae (Euphorbiaceae)

Abstract

An asymmetrical dimer of kaurane diterpene and monoterpene and four novel diterpenes were isolated from the roots of Croton limae, along with kaempferol-3-O-glucoside, ombuin- 3-O-rutinoside and acetyl aleuritolic acid. The cytotoxic activity of the kaurane diterpene was evaluated against colorectal adenocarcinoma (HCT-116), ovarian carcinoma (OVCAR-8) and glioma (SF-295) cell lines, exhibiting IC50 values of 7.14, 8.19 and > 10 µg mL−1, respectively.

Keywords
Croton limae ; diterpenes; terpenoid adduct; cytotoxic activity


Introduction

Croton is the second largest genus of the Euphorbiaceae family with around 1250 species dividided in 40 sections. The Croton section Argyroglossum comprises about 15 species characterized as shrubs and trees in the neotropics. In South America, there are ten reported species, six of which occurring in the Northeast of Brazil. Croton limae is endemic of this region and was often confused with the most related species C. argyrophyllus and C. tricolor, however, it was recently described by Gomes et al.1Gomes, A. N.; Sales, M. F.; Berry, P. E.; Brittonia 2010, 62, 206. as a new species belonging to this section.

Previous studies with northeastern Croton species have reported the occurrence of several classes of diterpenes with complex structures and interesting biological activities, including trachylobane, kaurane, crotofolane and casbane classes.2Silva-Filho, F. A.; Braz-Filho, R.; Silveira, E. R.; Lima, M. A. S.; Magn. Reson. Chem. 2011, 49, 370.

Silva-Filho, F. A.; Silva Junior, J. N.; Braz-Filho, R.; Simone, C. A.; Silveira, E. R.; Lima, M. A. S.; Helv. Chim. Acta 2013, 96, 1146.
-4Uchoa, P. K. S.; Silva Junior, J. N.; Silveira, E. R.; Lima, M. A. S.; Braz-Filho, R.; Costa-Lotufo, L. V.; Araujo, A. J.; Moraes, M. O.; Pessoa, C.; Quim. Nova 2013, 36, 778. The phytochemical study of C. limae here presented afforded an asymmetrical dimer (1), in addition to four new clerodanes including a glycosyde derivative (2-5) (Figure 1), kaempferol-3-O-glucoside,5Demirezer, L. O.; Gurbuz, F.; Guvenalp, Z.; Stroch, K.; Zeeck, A.; Turk. J. Chem. 2006, 30, 525.ombuin-3-O-rutinoside6Matsuda, H.; Morikawa, T.; Toguchida, I.; Yoshikawa, M.; Chem. Pharm. Bull. 2002, 50, 788. and acetyl aleuritolic acid.7Mcclean, S.; Dumont, M. P.; Reynolds, W. F.; Can. J. Chem. 1987, 65, 2519. In addition, the cytotoxicity of compound 1 was evaluated against colorectal adenocarcinoma (HCT-116), ovarian carcinoma (OVCAR-8) and glioma (SF-295) cell lines.

Figure 1
New terpenoids (1-5) isolated from the roots of Croton limae.

Experimental

General experimental procedures

Infrared (IR) spectra were recorded on a Perkin-Elmer FTIR 1000 spectrometer (Waltham, USA), using NaCl disc. The nuclear magnetic resonance (NMR) spectra were performed on Bruker Avance DRX 500 or DPX 300 instruments, equipped with an inverse detection probe head and z-gradient accessory. All pulse sequences were standard in the Bruker XWIN-NMR software, and all experiments were conducted at room temperature. The 1H and 13C chemical shifts are expressed in the d scale and were referenced to tetramethylsilane (TMS) through the residual solvent. High resolution mass spectra were recorded on an UltrOTOF-Q mass spectrometer (LC-IP-TOF model 225-07100-34, Shimadzu) either by positive or negative ionization modes of the ESI source. Optical rotations were obtained on a Perkin-Elmer Q-2000 polarimeter, at 589 nm and 25 °C. Column chromatography was performed over silica gel 60 (Vetec, 70-230 and 40-63 mesh), Sephadex LH-20 (Pharmacia) and cartridge SPE C18 (Phenomenex). Thin layer chromatography (TLC) was performed on precoated silica gel aluminum sheets (Merck) and the compounds were visualized by UV detection and by spraying with vanillin/perchloric acid/EtOH solution, followed by heating. The tested compounds were analysed using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) purchased by Sigma Aldrich Co. and high-throughput screening (HTS), Biomek 3000-Beckman Coulter (Inc. Fullerton, California, USA). Absorbance was measured on a DTX 880 Multimode Detector, Beckman Coulter, Inc. Fullerton, CA, USA.

Plant material

Croton limae A. P. Gomes, M. F. Sales & P. E. Berry was collected at Andaraí county, Bahia State, Northeast of Brazil, in December 2009. The specimen was authenticated by Prof Maria Lenise S. Guedes, from the Instituto de Biologia, Departamento de Botânica, Universidade Federal da Bahia (UFBA), Bahia, Brazil, and a voucher specimen (92958) was deposited at the Herbário Alexandre Leal Costa (ALCB), Universidade Federal da Bahia, Bahia, Brazil.

Extraction and isolation

Roots (1.7 kg) of C. limae were pulverized and extracted with hexane at room temperature. The solvent was removed under reduced pressure to yield a residue (40.2 g), which was then extracted with EtOH to yield the correspondent extract (32.1 g).

The hexane extract (40.2 g) was coarsely chromatographed over silica gel column yielding six fractions by elution with hexane (F-1), hexane:CHCl31:1 (F-2), CHCl3(F-3), CHCl3:EtOAc 1:1 (F-4), EtOAc (F-5) and MeOH (F-6). Successive flash chromatography of fraction F-2 (12.1 g) using CHCl3:EtOAc 8:2, CHCl3:EtOAC 7:3, CHCl3:EtOAc 1:1, EtOAc and MeOH, afforded compound1 (48.2 mg) and acetyl aleuritolic acid (95.0 mg). Fraction F-3 (10.4 g) was purified over Sephadex LH-20 by elution with MeOH to afford three fractions. Successive chromatography over Si gel of sub-fraction F-3(2) (3.75 g) using hexane:EtOAc 7:3 as an isocratic eluting mixture, yielded compound3 (13.8 mg). Silica gel column chromatography of the sub-fraction F-3(3) (1.54 g) using CH2Cl2:EtOAc 8:2, CH2Cl2:EtOAc 7:3, CH2Cl2:EtOAc 1:1, EtOAc and MeOH, yielded compound2 (22.4 mg).

The EtOH extract (32.1 g) was suspended in a mixture of MeOH:H2O 1:1 and submitted to partition with hexane, CHCl3, and EtOAc. The EtOAc fraction (3.6 g) was further purified over Sephadex LH-20 by elution with MeOH to afford five fractions. Fraction F-3 (1.10 g) was fractionated on a SPE C18 cartridge by elution with MeOH:H2O 9:1, MeOH:H2O 1:1 and H2O to afford compounds 4 (17.1 mg) and 5 (11.6 mg). Fraction F-5 (977.3 mg) was submitted to the same procedure to afford kaempferol-3-O-glucoside (7.2 mg) and ombuin-3-O-rutinoside (10.4 mg).

Cytotoxic assays

Tumor cell lines HCT-116, OVCAR-8, and SF-295 were provided by the National Cancer Institute (Bethesda, MD, USA). Cancer cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mmol L−1 glutamine, 100 U mL−1 penicillin, and 100 µg mL−1 streptomycin, at 37 °C with 5% CO2. Cytotoxicity of compound 1 was evaluated using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction assay.8Mosmann, T. J.; J. Immunol. Methods 1983, 65, 55. For all experiments, cells were plated in 96 well plates (105 cells per well for adherent cells or 3 × 105 cells per well for suspended cells in 100 µL of medium). The tested compounds (0.05-25 g mL−1) dissolved in dimethyl sulfoxide (DMSO) were added to each well incubated for 72 h. Doxorubicin was used as the positive control. Control groups received the same amount of DMSO. After 69 h of incubation, the supernatant was replaced by fresh medium containing MTT (0.5 mg mL−1) for 3 h. The solid MTT formazan product formed was dissolved in 150 µL of DMSO, and absorbance was measured at 595 nm.

15-Oxo-17(10’-α-pinenyl)-ent-kauran-18-oic acid (1)

White solid; m.p. 122.3-123.9 °C; [a]D25 −56.1 (c 0.1, CH2Cl2); IR (KBr) νmax / cm−1 2985, 2914, 2866, 1726, 1696, 1459, 1446, 1386, 1265, 1178, 1109, 1065, 1002, 950, 885, 802, 704, 665; 1H NMR (500 MHz, CDCl3) and 13C NMR (125 MHz, CDCl3) see Tables 1 and 2; HRESIMS (negative mode) m/z 451.3250 [M − H]+ (calcd. for C30H43O3, 451.3213).

Table 1
1H NMR chemical shifts of compounds 1-5(δ in ppm, J in Hz)
Table 2
13C NMR chemical shifts of compounds 1-5(δ in ppm)

3-Oxo-15,16-epoxy-4α,12-dihydroxy-ent-neo-clerodan-13(16),14-diene (2)

Yellow solid; m.p. 115.5-117.0 °C; [a]D25 −3.1 (c 0.1, MeOH); IR (KBr) νmax / cm−1 3447, 2935, 2869, 1707, 1453, 1375, 1161, 1083, 940; 1H NMR (300 MHz, CDCl3) and 13C NMR data (75 MHz, CDCl3) see Tables 1 and 2; HRESIMS (positive mode) m/z 357.2038 [M + Na]+ (calcd. for C20H30O4Na, 357.2042).

15,16-Epoxy-3α,4α,12-trihydroxy-ent-neo-clerodan-13(16),14-diene (3)

Colorless solid; m.p. 129.7-131.2 °C; [α]D25 −2.0 (c0.1, MeOH); IR (KBr) νmax / cm−1 3287, 2926, 2865, 1597, 1502, 1440, 1386, 1302, 1161, 1119, 1067, 1026, 1009, 971, 956, 875, 790, 718, 661; 1H NMR (500 MHz, MeOD) and 13C NMR (125 MHz, MeOD) see Tables 1 and 2; HRESIMS (positive mode) m/z 359.2168 [M + Na]+ (calcd. for C20H32O4Na, 359.2193).

3α,4α,15,16-Tetrahydroxy-ent-neo-cleroda-13E-ene (4)

White solid; m.p. 106.5-108.2 °C; [a]D25 −9.7 (c 0.1, MeOH); IR (KBr) νmax / cm−1 3349, 2931, 1714, 1653, 1453, 1378, 1276, 1093, 1051, 1011, 978, 910, 865, 721; 1H NMR (300 MHz, MeOD) and 13C NMR (75 MHz, MeOD) see Tables 1 and 2; HRESIMS (positive mode) m/z 363.2524 [M + Na]+ (calcd. for C20H36O4Na, 363.2506).

3,12-Dioxo-15,16-epoxy-4α-hydroxy-6-(β-glucopyranosyl)-ent-neo-clerodan-13(16),14-diene (5)

White solid; m.p. 108.6-109.8 °C; [a]D25 −82.0 (c 0.1, MeOH); IR (KBr) νmax / cm−1 3414, 2926, 1699, 1664, 1377, 1151, 1028, 870, 796; 1H NMR (300 MHz, MeOD) and 13C NMR (75 MHz, MeOD) see Tables 1 and 2; HRESIMS (positive mode) m/z 533.2357 [M + Na]+ (calcd. for C26H38O10Na 533.2409).

Results and Discussion

Compound 1, a white solid, has a molecular formula of C30H44O3 as established by the ion at m/z 451.3250 [M − H]+ in the high-resolution electrospray ionisation mass spectrometry (HRESIMS). The IR spectrum showed bands at 1728 and 1697 cm−1 relative to carbonyl groups and at 3500 cm−1 relative to hydroxyl. The 1H NMR spectrum of 1 displayed four distinct methyl singlets at δH 1.26 (CH3-8’), 1.15 (CH3-19), 1.10 (CH3-20) and 0.82 (CH3-9’), and an olefinic proton at δH 5.21 (br s, H-3’), besides several signals attributable to hydrogens attached to sp3 carbons (Table 1). The 13C NMR spectrum with the aid of DEPT and HMQC experiments indicated thirty signals relative to two carbonyls at δC 184.9 (C-18) and 224.1 (C-15), two unsaturated carbons at δC 148.0 (C-2’) and 116.6 (C-3’), and twenty six other signals for non functionalized sp3 carbons (four methyls, twelve methylenes, six methines and four quaternaries) (Tables 1 and 2). The HMBC spectrum provided evidences for the ABC rings of a kaurane-type moiety by the long-range correlations between the hydrogens of the methyl at δH 1.10 (H-20) with the methylene carbon at δC 38.6 (C-1) and the methines at δC49.5 (C-5) and 52.3 (C-9), besides the correlations of the methyl at δH 1.15 (H-19) with the methylene carbon at δC 36.9 (C-3) and the methine at δC 49.5 (C-5), and with the carbonyl at δC 184.9 (C-18). Moreover, the correlations between the hydrogen at δH 1.20 (H-9), with the carbons at δC 18.0 (C-20), 49.5 (C-5), 38.6 (C-1), 24.8 (C-12) and 37.4 (C-14), and the hydrogen at δH 2.48 (H-13) with the carbons at δC 53.2 (C-8), 17.7 (C-11) and the carbonyl at δC 224.1 (C-15) confirmed this suggestion. From the above data, the two carbonyl groups were undoubtedly located at C-18 and C-15, respectively. On the basis of spectroscopic comparison of the diterpene moiety with those related for the ent-kaur-16-en-15-oxo-18-oic acid a great similarity has been observed between both compounds, and confirmed the partial structure.9Monte, F. J. Q.; Dantas, E. M. G.; Braz-Filho, R.; Phytochemistry 1988, 27, 3209.

Additionally, were also observed in the HMBC spectrum the correlations of the methine at δH 2.10 (H-16) with carbons at δC 24.8 (C-12), 53.2 (C-8) and 35.5 (C-10’), besides the correlations of the olefinic methine at δH 5.21 (H-3’) with carbons at δC 35.5 (C-10’), 45.8 (C-1’) and 41.0 (C-5’), and those of remaining methyl groups at δH0.82 (H-9’) and 1.26 (H-8’) with carbons δC45.8 (C-1’) and 41.0 (C-5’). On the basis of the foregoing evidence and comparison with the literature data, the monoterpene moiety was characterized as α-pinene.1010 Lee, S. G.; Magn. Reson. Chem. 2002, 40, 311. Thus, the structure of 1 was fully established as an unprecedented asymmetrical dimer of a kaurane diterpene bearing a monoterpene unit at C-16. The relative stereochemistry was elucidated from NOESY data and comparison with kaurane-type diterpenoids. In this spectrum were observed correlation between the both methyls groups at δη 1.15 (CH3-19) and 1.10 (CH3-20), as well as the correlation between the hydrogens at δH 1.77 (H-5) and 1.20 (H-9). The orientation of the monoterpene group at C-16 was assigned as β due the strong nOe correlations observed between the hydrogens at δH 2.10 (H-16) and 1.30 (H-14); and δH2.43 (H-14) and 1.10 (CH3-20) (Figure 2). This finding was confirmed by the chemical shift observed for C-12 at δC 24.8 that was shielded in comparison to the ent-kaur-16-en-15-oxo-18-oic acid at δC 32.4. This effect can be explained by the γ-gauche interaction of the C-12 with the methylene group at C-17, as observed for other reported kaurane dimers with β orientation.1111 Han, Q.; Lu, Y.; Zhang, L.; Zhengb, Q.; Suna, H.; Tetrahedron Lett. 2004, 45, 2833.,1212 Saepou, S.; Pohmakotr, M.; Reutrakul, V.; Yoosook, C.; Kasisisit, J.; Napaswad, C.; Tuchinda, P.; Planta Med. 2010, 76, 721. Thus, compound 1 was determined to be the new 15-oxo-17(10’-α-pinenyl)-kauran-18-oic acid.

Figure 2
Important dipolar couplings observed through the NOESY for compound 1.

Compound 2 was obtained as a yellow solid. Its molecular formula C20H30O4 was determined by HRESIMS by the ion at m/z 357.2038 [M + Na]+. The IR spectrum displayed diagnostic absorption bands referring to hydroxyl and carbonyl groups at 3447 and 1707 cm−1, respectively. The 13C NMR spectrum displayed twenty signals associated with four methyl groups (δC 15.3, 16.0, 17.9 and 21.9), five methylenes and six methines (one of which oxygenated at δC63.4 and three olefinic at δC 138.4, 131.5 and 108.4). In addition, five non-hydrogenated carbons including a carbonyl (δC 216.0) were observed (Table 2). The 1H NMR spectrum revealed signals consistent with the presence of four methyls, three angular at δH 0.74 (s, CH3-20), 0.81 (s, CH3-19) and 1.37 (s, CH3-18), and a tertiary at δH 0.79 (d, J 6.7 Hz, CH3-17), an oxymethine at δH4.92 (dd, J 5.0, 1.5 Hz, H-12), and three olefinic methines, one at δH 6.38 (br s, H-14) and two overlapped at δH7.38 (m, H-15 and H-16) (Table 1). Signals relative to a subsystem constituted by five hydrogens belonging two diastereotopic methylenes at δH 2.56 (dt, J 14.2, 4.9 Hz, H-2β), 2.39 (ddd, J 14.2, 4.9, 1.9 Hz, H-2α), 2.22 (m, H-1β), and 1.68 (m, H-1α), and a methine at δH 2.51 (dd, J 12.4, 2.9 Hz, H-10), were observed by analysis of the 1H-1H COSY experiment. The deshielded diastereotopic protons of a methylene at δH 2.56 and 2.39 (2H-2) were attributed to the methylene “α” to a ketone group, due to the constant of 14.2 Hz. Furthermore, the coupling between both methylenes at δH 1.64 (m, H-6eq) and 1.50 (m, H-6ax), 1.42 (H-7eq) and 1.44 (and H-7ax), the latter showing correlation with the methine at δH 1.70 (m, H-8), revealed another subsystem of five hydrogens, which were placed between two quaternary sp3 carbon atoms. In addition, the remaining methylene at δH 1.95 (dd, J 15.7, 9.0 Hz, H-11eq) and 1.59 (m, H-11ax) showed correlations with the oxymethine at δH 4.92 (dd, J 9.0, 1.5 Hz, H-12). The proposed assignment for the clerodane skeleton contained a β-monosubstituted furan moiety9Monte, F. J. Q.; Dantas, E. M. G.; Braz-Filho, R.; Phytochemistry 1988, 27, 3209.,1313 Krebs, H. C.; Ramiarantsoa, H.; Phytochemistry 1996, 41, 561. was supported by analyzing the HMBC spectrum, through the long-range correlations of the methyl groups at δH 0.74 (H-20) with carbons at δC 45.9 (C-11), 42.2 (C-10) and 37.3 (C-8), and those of the methyl at δH 0.79 (H-17) with carbons at δC 39.9 (C-9) and 26.8 (C-7). The allocation of the hydroxyl group at C-12 was deduced on the basis of the correlations of the oxymethine at δH 4.92 (H-12) with the carbon at δC 39.9 (C-9), and with the carbons of the furan moiety at δC 108.4 (C-14) and 138.4 (C-16). On the other hand, the correlations of the methyl at δH 1.37 (CH3-18) and hydrogens of the methylene at δH 1.68 and 2.22 (2H-1) with the carbonyl at δC 216.0 (C-3), besides the concomitant correlations of the hydrogens at δH 0.81 (CH3-19), 2.51 (H-10), 2.39 and 2.56 (2H-2) with the non-hydrogenated oxygenated carbon at δC 81.8 (C-4), are consistent with the presence of a carbonyl at C-3 and a hydroxyl group at C-4. The configuration of the hydroxyl at C-4 α-oriented was definitively determined on the basis of diagnostic nOe correlations observed between the methyl at δH 1.37 (H-18) and the methines at δH 2.51 (H-10) and 4.92 (H-12) in the NOESY experiment (Figure 3). In this spectrum were also observed important correlations between the hydrogen at δH 2.51 (H-10) with the hydrogens at δH1.37 (H-18) and 1.67 (H-12), as well as correlations between the hydrogens at δH 0.74 (H-20) with the hydrogens at δH 0.81 (H-19) and 1.68 (H-1a) (Figure 3) charactering a trans-decalin system. These data suggested that the lateral chain at C-19 was β-oriented (equatorial), confirming the final structure of compound 2 as the new 3-oxo-15,16-epoxy-4α,12-dihydroxy-ent-neo-clerodan-13(16),14,diene.1414 Maciel, M. A. M.; Cortez, J. K. P. C.; Gomes, E. F. S.; Rev. Fitos 2006, 2, 54.

Figure 3
Dipolar coupling observed through the NOESY experiment for compound 2.

Compound 3 was obtained as a colorless solid. The molecular formula C20H32O4 was established by HRESIMS from the ion at m/z 359.2168 [M + Na]+. The IR spectrum showed the presence of a hydroxyl band at 3287 cm−1. Analysis of the 13C NMR spectrum of 3 revealed that the chemical shifts were similar to those observed for compound2 (Table 2), except for the absence of the signals relative to the carbonyl and the presence of an extra oxymethine at δC 77.9 (C-3) (Table 2). The 1H NMR spectrum corroborated these observations, through the presence of an additional signal for an oxymethine at δH3.48 (t, J 2.5 Hz, H-3). The suggestion that the carbonyl group at C-3 for compound 2 has been reduced in 3, was confirmed by the diagnostic long-range correlations in the HMBC spectrum observed between the oxymethine proton at δH 3.48 (H-3) and the carbons at δC 18.1(C-1), 43.6 (C-5) and 23.4 (C-18). The relative stereochemistry of the hydroxyl group at C-3 was defined as α-oriented (equatorial) by the small value of the coupling constant (J2.5 Hz) of the triplet observed for H-3. As for compound 2, the NOESY experiment showed the same correlations between the hydrogens at δH 1.38 (H-10) with the hydrogens at δH 1.06 (H-18) and 4.74 (H-12), as well as correlations between the hydrogens at δH 0.76 (CH3-20) with the hydrogens at δH 1.13 (CH3-19) and 1.54 (H-1a), and suggested that the lateral chain at C-19 was also β-oriented (equatorial). Thus, the final structure of compound 3 was elucidated as the new 15,16-epoxy-3α,4α,12-trihydroxy-ent-neo-clerodan-13(16)14-diene.

Compound 4 was obtained as a white solid. The molecular formula C20H36O4 was established by HRESIMS by the ion at m/z 363.2524 [M + Na]+. The IR spectrum showed hydroxyl and C=C stretching bands at 3349 and 1653 cm−1, respectively. The 1H NMR spectrum signals indicated a close relationship with those observed for compound 3, mainly relative to the decalin system (Table 1). The differences found were related to the presence of just one olefinic proton at δH 5.47 (t, J6.8 Hz, H-14), and two oxymethylenes at δH 4.14 (d, J6.8 Hz, H-15) and 4.10 (s, 2H-16), besides the disappearance of the signals relative to the furan moiety and the oxymethine at C-12. These data suggested that the furan moiety of compound 3 was opened in 4. This was confirmed by comparison of their 13C NMR data, since the typical furan values of compound 2 were here replaced by two oxymethylene carbons at δC59.0 (C-15) and 60.5 (C-16), and a double-bond at δC 144.1 (C-13) and 127.3 (C-14) on 3 (Table 2). The NOESY experiment showed correlations between the hydrogen at δH 1.87 (H-10) with the hydrogens at δH 1.50 (H-8), 2.03 (H-2a), 1.67 (H-6b) and 1.19 (CH3-18). In addition, it was observed the correlations between the hydrogens at δH 0.75 (CH3-20) with hydrogens at δH 1.12 (CH3-19), 1.40 (H-11b), 1.49 (H-7a) and 1.58 (H-1a), and the correlation of the hydrogen at δH 3.48 (H-3) with hydrogens at δH 1.19 (CH3-18). From the above data we can assume that the hydroxyls groups at C-3 and C-4, and the lateral chain at C-19 have the same configuration as in compound 3, so compound 4 was thus characterized as the new 3α,4α,15,16-tetrahydroxy-ent-neo-(E)-cleroda-13-ene.

Compound 5 was obtained as a white solid with a molecular formula C26H38O10 as determined by the peak at m/z 533.2409 [M + Na]+.The IR spectrum implied the presence of hydroxyl and carbonyl groups at 3414 and 1699 cm−1, respectively. From the 1H NMR spectrum, a monossubstituted furan system was defined by the typical signals at δH 8.02 (br s, H-16), 7.59 (br s, H-15) and 6.78 (br s, H-14). The magnitude of geminal coupling constants observed for the deshielded methylene groups at δH 2.45 (td, J 14.2, 6.8 Hz, H-2eq), 2.33 (dq, J 14.2, 2.0 Hz, H-2ax), 2.92 (d, J 16.1 Hz, H-11eq), and 2.86 (d, J 16.1 Hz, H-11ax) were characteristic of “α” methylene ketone groups (Table 1). In addition, an β-anomeric proton at δH4.45 (d, J7.7 Hz, H-1’), and the signals in the region of δH 4.45-3.13, suggested the presence of a sugar unit, that was determined to be the glucose based on the chemical shifts of the 1H and 13C NMR spectrum in comparison with literature.1515 Oliveira, P. R. N.; Testa, G.; Sena, S. B.; Costa, W. F.; Sarragioto, M. H.; Santin, S. M. O.; Souza, M. C.; Quim. Nova 2008, 31, 755. The β-anomeric configuration was judged by the larger value of the coupling constant (J 7.7 Hz) of the doublet related to the anomeric hydrogen.

The location of the hydroxyl group at C-4 was established by the concomitant long-range correlations of hydrogens at δH 0.97 (CH3-19), 2.64 (H-10) and 3.95 (H-6) with the carbon at δC 83.9 (C-4), in the HMBC spectrum. Moreover, the correlations between the hydrogen at δH 1.45 (CH3-18) with the carbons at δC 51.0 (C-5) and 214.1 (C-3), besides the correlation of the hydrogens at δH 0.97 (CH3-19) and the anomeric proton at δH 4.45 (H-1’) with the carbon at δC 85.4 (C-6) confirmed the locations of carbonyl and glucosyl at C-3 and C-6, respectively. On the other hand, the correlations observed between the hydrogens at δH0.87 (CH3-20) and 2.64 (H-10) with the carbon at δC47.8 (C-11), determined the location of the other carbonyl group at C-12. The equatorial orientations of the glucosyl group and hydroxyl groups at C-6 and C-3, respectively, were determined based on the value of the coupling constant observed for the oxymethine H-6 (J 11.6, 3.9 Hz), and by nOe correlations observed between the hydrogens at δH2.64 (H-10) with those at δH 1.45 (CH3-18), 2.05 (H-8) and 3.95 (H-6). Thus, compound 5 was characterized as the new 3,12-dioxo-15,16-epoxy-4α-hydroxy-6-(β-glucopyranosyl)-ent-neo-clerodan-13(16),14-diene.

The isolation of diterpene dimers is reported to several species of different genera, as symmetrical compounds with icexetane, labdane and kaurane skeletons.1616 Suresh, G.; Babu, K. S.; Rao, M. S. A.; Rao, V. R. S.; Yadav, P. A.; Nayak, V. L.; Ramakrishna, S.; Tetrahedron Lett. 2011, 52, 5016.

17 Zhang, B.; Wang, H.; Luo, X.; Du, Z.; Shen, J.; Wu, H.; Zhang, X.; Helv. Chim. Acta 2012, 95, 1672.

18 Sato, K.; Sugawara, K.; Takeuchi, H.; Park, H.; Akiyama, T.; Koyama, T.; Aoyagi, Y.; Takeya, K.; Tsugane, T.; Shimura, S.; Chem. Pharm. Bull. 2008, 56, 1691.
-1919 Hong, S. S.; Lee, S. A.; Lee, C.; Han, X. H.; Choe, S.; Kim, N.; Lee, D.; Lee, C.; Kim, Y.; Hong, J. T.; Lee, M. K.; Hwang, B.Y.; J. Nat. Prod. 2011, 74, 2382. The occurrence of asymmetrical dimers are more restricted, and generally involve the junction of two diterpene monomers.2020 Hasan, C. M.; Healey, T. M.; Waterman, P. G.; Phytochemistry 1985, 24, 192.,2121 Piacente, S.; Aquino, R.; Tommasi, N.; Pizza, C.; Ugaz, O. L.; Orellana, D. C.; Mahmood, N.; Phytochemistry 1994, 36, 991. In Croton genus, this feature is limited to the species C. tonkinensis and C. micans, as symmetrical structures of ent-kaurene.2222 Vivas, J.; Sojo, F.; Chavez, K.; Suarez, A. I.; Arvelo, F.; Lett. Drug Des. Discovery 2013, 10, 693.,2323 Thuong, P. T.; Pham, T. H. M.; Le, T. V. T.; Dao, T. T.; Dang, T. T.; Nguyen, Q. T.; Oh, W. K.; Bioorg. Med. Chem. 2012, 22, 1122. The structure of an asymmetrical dimer formed by the junction between diterpene and monoterpene moities, as it is the case for compound 1, is a feature never reported in the literature before.

The cytotoxic activity of compound 1 was evaluated against colorectal adenocarcinoma (HCT-116), ovarian carcinoma (OVCAR-8) and glioma (SF-295) cell lines, exhibiting IC50 values of 7.14, 8.19 and > 10 µg mL−1, respectively. Previous studies showed the cytotoxicity ofent-kaur-16-en-15-oxo-18-oic acid against promyelocytic leukemia (L-60), glyoblastoma (SF-295), colon cancer (HCT-8) and melanoma (MDAMB-435) cell lines.2424 Santos, H. S.; Barros, F. W. A.; Albuquerque, M. R. J. R.; Bandeira, P. N.; Pessoa, C.; Braz-Filho, R.; Monte, F. J. Q.; Leal-Cardoso, J. H.; Lemos, T. L. G.; J. Nat. Prod. 2009, 72, 1884. Since then the ent-kaur-16-en-15-oxo-18-oic acid is one monomer of compound 1 our results are in agreement with these findings, and with the cytotoxicity associated to kaurenoic acid derivatives.2525 Dutra, L. M.; Bomfim, L. M.; Rocha, S. L. A.; Nepel, A.; Soares, M. B. P.; Barison, A.; Costa, E. V.; Bezerra, D. P.; Bioorg. Med. Chem. 2014, 24, 3315.

26 Fernandes, V. C.; Pereira, S. I. V.; Copped, J.; Martins, J. S.; Rizo, W. F.; Beleboni, R. O.; Marins, M.; Pereira, P. S.; Pereira, A. M. S.; Fachin, A. L.; GMR, Genet. Mol. Res. 2013, 12, 1005.

27 Cavalcanti, B. C.; Ferreira, J. R. O.; Moura, D. J.; Rosa, R. M.; Furtado, G. V.; Burbano, R. R.; Silveira, E. R.; Lima, M. A. S.; Camara, C. A. G.; Saffi, J.; Henriques, J. A. P.; Rao, V. S. N.; Costa-Lotufo, L. V.; Moraes, M. O.; Pessoa, C.; Mutat. Res., Genet. Toxicol. Environ. Mutagen. 2010, 701, 153.
-2828 Rosseli, S.; Maggio, A.; Eiroa, C.; Formisano, C.; Bruno, M.; Irace, C.; Maffettone, C.; Mascolo, N.; Planta Med. 2008, 74, 1285.

Conclusions

Chemical investigation of C. limae yielded an unusual asymmetrical dimer of a kaurane derivative with the monoterpene α-pinene (1), besides four new clerodanes (2-5). Based on the data collected from three independent experiments, the results showed that compound 1 exhibited a moderate cytotoxic effect against HCT-116 and OVOCAR-8 cancer cell lines with IC50 values of 7.14, 8.19 and > 10 µg mL−1, respectively. These facts are in agreement with the knowledge that the Croton genus is an abundant source of several classes of structurally complex and bioactive diterpenes, which justify the efforts in pursuing the phytochemical study of other Croton species from the northeastern Brazil.

  • Supplementary Information
    The NMR and mass spectra of compounds 1-5 are available at http://jbcs.sbq.org.br as a free-access PDF file.

Acknowledgements

The authors are grateful to CNPq/CAPES/PADCT/PRONEX/FUNCAP/FINEP for the fellowships and financial support. We also thank to CENAUREMN and LEMANOR of Universidade Federal do Ceará, for acquisition of NMR and high resolution mass spectra, respectively.

References

  • 1
    Gomes, A. N.; Sales, M. F.; Berry, P. E.; Brittonia 2010, 62, 206.
  • 2
    Silva-Filho, F. A.; Braz-Filho, R.; Silveira, E. R.; Lima, M. A. S.; Magn. Reson. Chem 2011, 49, 370.
  • 3
    Silva-Filho, F. A.; Silva Junior, J. N.; Braz-Filho, R.; Simone, C. A.; Silveira, E. R.; Lima, M. A. S.; Helv. Chim. Acta 2013, 96, 1146.
  • 4
    Uchoa, P. K. S.; Silva Junior, J. N.; Silveira, E. R.; Lima, M. A. S.; Braz-Filho, R.; Costa-Lotufo, L. V.; Araujo, A. J.; Moraes, M. O.; Pessoa, C.; Quim. Nova 2013, 36, 778.
  • 5
    Demirezer, L. O.; Gurbuz, F.; Guvenalp, Z.; Stroch, K.; Zeeck, A.; Turk. J. Chem 2006, 30, 525.
  • 6
    Matsuda, H.; Morikawa, T.; Toguchida, I.; Yoshikawa, M.; Chem. Pharm. Bull. 2002, 50, 788.
  • 7
    Mcclean, S.; Dumont, M. P.; Reynolds, W. F.; Can. J. Chem 1987, 65, 2519.
  • 8
    Mosmann, T. J.; J. Immunol. Methods 1983, 65, 55.
  • 9
    Monte, F. J. Q.; Dantas, E. M. G.; Braz-Filho, R.; Phytochemistry 1988, 27, 3209.
  • 10
    Lee, S. G.; Magn. Reson. Chem. 2002, 40, 311.
  • 11
    Han, Q.; Lu, Y.; Zhang, L.; Zhengb, Q.; Suna, H.; Tetrahedron Lett 2004, 45, 2833.
  • 12
    Saepou, S.; Pohmakotr, M.; Reutrakul, V.; Yoosook, C.; Kasisisit, J.; Napaswad, C.; Tuchinda, P.; Planta Med 2010, 76, 721.
  • 13
    Krebs, H. C.; Ramiarantsoa, H.; Phytochemistry 1996, 41, 561.
  • 14
    Maciel, M. A. M.; Cortez, J. K. P. C.; Gomes, E. F. S.; Rev. Fitos 2006, 2, 54.
  • 15
    Oliveira, P. R. N.; Testa, G.; Sena, S. B.; Costa, W. F.; Sarragioto, M. H.; Santin, S. M. O.; Souza, M. C.; Quim. Nova 2008, 31, 755.
  • 16
    Suresh, G.; Babu, K. S.; Rao, M. S. A.; Rao, V. R. S.; Yadav, P. A.; Nayak, V. L.; Ramakrishna, S.; Tetrahedron Lett. 2011, 52, 5016.
  • 17
    Zhang, B.; Wang, H.; Luo, X.; Du, Z.; Shen, J.; Wu, H.; Zhang, X.; Helv. Chim. Acta 2012, 95, 1672.
  • 18
    Sato, K.; Sugawara, K.; Takeuchi, H.; Park, H.; Akiyama, T.; Koyama, T.; Aoyagi, Y.; Takeya, K.; Tsugane, T.; Shimura, S.; Chem. Pharm. Bull 2008, 56, 1691.
  • 19
    Hong, S. S.; Lee, S. A.; Lee, C.; Han, X. H.; Choe, S.; Kim, N.; Lee, D.; Lee, C.; Kim, Y.; Hong, J. T.; Lee, M. K.; Hwang, B.Y.; J. Nat. Prod. 2011, 74, 2382.
  • 20
    Hasan, C. M.; Healey, T. M.; Waterman, P. G.; Phytochemistry 1985, 24, 192.
  • 21
    Piacente, S.; Aquino, R.; Tommasi, N.; Pizza, C.; Ugaz, O. L.; Orellana, D. C.; Mahmood, N.; Phytochemistry 1994, 36, 991.
  • 22
    Vivas, J.; Sojo, F.; Chavez, K.; Suarez, A. I.; Arvelo, F.; Lett. Drug Des. Discovery 2013, 10, 693.
  • 23
    Thuong, P. T.; Pham, T. H. M.; Le, T. V. T.; Dao, T. T.; Dang, T. T.; Nguyen, Q. T.; Oh, W. K.; Bioorg. Med. Chem 2012, 22, 1122.
  • 24
    Santos, H. S.; Barros, F. W. A.; Albuquerque, M. R. J. R.; Bandeira, P. N.; Pessoa, C.; Braz-Filho, R.; Monte, F. J. Q.; Leal-Cardoso, J. H.; Lemos, T. L. G.; J. Nat. Prod 2009, 72, 1884.
  • 25
    Dutra, L. M.; Bomfim, L. M.; Rocha, S. L. A.; Nepel, A.; Soares, M. B. P.; Barison, A.; Costa, E. V.; Bezerra, D. P.; Bioorg. Med. Chem 2014, 24, 3315.
  • 26
    Fernandes, V. C.; Pereira, S. I. V.; Copped, J.; Martins, J. S.; Rizo, W. F.; Beleboni, R. O.; Marins, M.; Pereira, P. S.; Pereira, A. M. S.; Fachin, A. L.; GMR, Genet. Mol. Res. 2013, 12, 1005.
  • 27
    Cavalcanti, B. C.; Ferreira, J. R. O.; Moura, D. J.; Rosa, R. M.; Furtado, G. V.; Burbano, R. R.; Silveira, E. R.; Lima, M. A. S.; Camara, C. A. G.; Saffi, J.; Henriques, J. A. P.; Rao, V. S. N.; Costa-Lotufo, L. V.; Moraes, M. O.; Pessoa, C.; Mutat. Res., Genet. Toxicol. Environ. Mutagen. 2010, 701, 153.
  • 28
    Rosseli, S.; Maggio, A.; Eiroa, C.; Formisano, C.; Bruno, M.; Irace, C.; Maffettone, C.; Mascolo, N.; Planta Med. 2008, 74, 1285.

Data availability

Publication Dates

  • Publication in this collection
    Aug 2015

History

  • Received
    04 Mar 2015
  • Accepted
    15 May 2015
Sociedade Brasileira de Química Instituto de Química - UNICAMP, Caixa Postal 6154, 13083-970 Campinas SP - Brazil, Tel./FAX.: +55 19 3521-3151 - São Paulo - SP - Brazil
E-mail: office@jbcs.sbq.org.br